| 000 | 01262 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511151305.0 | ||
| 264 | 0 | _c19760602 | |
| 008 | 197606s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/0024-3205(76)90063-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVince, R | |
| 245 | 0 | 0 |
_aAn active puromycin analog derived from a non-nephrotoxic aminonucleoside. _h[electronic resource] |
| 260 |
_bLife sciences _cFeb 1976 |
||
| 300 |
_a345-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aEscherichia coli |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPeptidyl Transferases _xmetabolism |
| 650 | 0 | 4 |
_aProteinuria _xchemically induced |
| 650 | 0 | 4 |
_aPuromycin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPuromycin Aminonucleoside _xtoxicity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aRibosomes _xmetabolism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aAlmquist, R G | |
| 700 | 1 | _aRitter, C L | |
| 700 | 1 | _aShirota, F N | |
| 700 | 1 | _aNagasawa, H T | |
| 773 | 0 |
_tLife sciences _gvol. 18 _gno. 3 _gp. 345-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0024-3205(76)90063-1 _zAvailable from publisher's website |
| 999 |
_c786579 _d786579 |
||